Literature DB >> 16923037

Chronic mental illness and community treatment resistance.

Alex Holmes1, Mark Hodge, Simon Lenten, John Fielding, David Castle, Dennis Velakoulis, Gail Bradley.   

Abstract

OBJECTIVES: The movement from institutional to community care has been a key component of national mental health reform in Australia. In Victoria, where a model of community care has been fully implemented, a specialized forensic hospital is the sole remaining stand-alone psychiatric inpatient facility and access to long-term inpatient beds is severely limited. Clinical experience suggests that some high-needs patients are not well serviced by this structure. These patients are placing an increasing burden on a wide range of community services outside mental health. This paper aims to define more clearly this patient group, explore the limitations of their management and outline potential pathways for service development.
CONCLUSIONS: A population of complex patients with chronic mental illness are not effectively contained within a 'good enough' community-based mental health system. Active debate is required regarding the community's willingness to tolerate the risks and challenges that arise from the current approach. A collaborative care model involving case-based and incentive funding in combination with community-integrated complex care units may improve the care of these patients.

Entities:  

Mesh:

Year:  2006        PMID: 16923037     DOI: 10.1080/j.1440-1665.2006.02284.x

Source DB:  PubMed          Journal:  Australas Psychiatry        ISSN: 1039-8562            Impact factor:   1.369


  2 in total

1.  Lessening Homelessness Among Persons with Mental Illness: A Comparison of Five Randomized Treatment Trials.

Authors:  Russell K Schutt; Richard L Hough; Stephen M Goldfinger; Anthony F Lehman; David L Shern; Elie Valencia; Patricia A Wood
Journal:  Asian J Psychiatr       Date:  2009-10-01

2.  Treatment of personality disorder using a whole of service stepped care approach: A cluster randomized controlled trial.

Authors:  Brin F S Grenyer; Kate L Lewis; Mahnaz Fanaian; Beth Kotze
Journal:  PLoS One       Date:  2018-11-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.